pI: 9.2721 |
Length (AA): 521 |
MW (Da): 56595 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 205 | 4n5a (A) | 307 | 509 | 12.00 | 0 | 0.01 | 0.471255 | -0.28 |
277 | 515 | 5f6l (B) | 287 | 503 | 28.00 | 0 | 0.98 | 0.381433 | 0.51 |
277 | 515 | 3toj (A) | 287 | 503 | 31.00 | 0 | 0.83 | 0.411433 | 0.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Oocyst. | Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_128823)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G51450 | protein TRAUCO |
Brugia malayi | Bm1_16295 | SPRY domain containing protein |
Candida albicans | CaO19.11446 | similar to S. pombe ash2 (SPBC13G1.08c) and to S. cerevisiae BRE2 (YLR015W) component of COMPASS histone methylation complex |
Candida albicans | CaO19.3964 | similar to S. pombe ash2 (SPBC13G1.08c) and to S. cerevisiae BRE2 (YLR015W) component of COMPASS histone methylation complex |
Caenorhabditis elegans | CELE_Y17G7B.2 | Protein ASH-2, isoform B |
Cryptosporidium hominis | Chro.10092 | similar to ash2 |
Cryptosporidium parvum | cgd1_740 | hypothetical protein |
Drosophila melanogaster | Dmel_CG6677 | absent, small, or homeotic discs 2 |
Echinococcus granulosus | EgrG_000489600 | set1:ash2 histone methyltransferase complex |
Echinococcus multilocularis | EmuJ_000489600 | set1:ash2 histone methyltransferase complex |
Homo sapiens | ENSG00000129691 | ash2 (absent, small, or homeotic)-like (Drosophila) |
Loa Loa (eye worm) | LOAG_02488 | SPRY domain-containing protein |
Loa Loa (eye worm) | LOAG_12574 | SPRY domain-containing protein |
Mus musculus | ENSMUSG00000031575 | ash2 (absent, small, or homeotic)-like (Drosophila) |
Neospora caninum | NCLIV_004990 | SPRY domain containing protein, related |
Oryza sativa | 4349756 | Os11g0145500 |
Oryza sativa | 9268228 | Os11g0145600 |
Oryza sativa | 4349761 | Os11g0146500 |
Oryza sativa | 4351479 | Os12g0143200 |
Plasmodium berghei | PBANKA_0704300 | SPRY domain, putative |
Plasmodium falciparum | PF3D7_0826300 | SPRY domain, putative |
Plasmodium knowlesi | PKNH_1320500 | SPRY domain, putative |
Plasmodium vivax | PVX_089045 | hypothetical protein, conserved |
Plasmodium yoelii | PY05573 | similar to ash2 |
Saccharomyces cerevisiae | YLR015W | Bre2p |
Schistosoma japonicum | Sjp_0100120 | Set1/Ash2 histone methyltransferase complex subunit ASH2, putative |
Schistosoma mansoni | Smp_142170 | trithorax protein ash2 |
Schmidtea mediterranea | mk4.001515.11 | Set1/Ash2 histone methyltransferase complex subunit ASH2 |
Toxoplasma gondii | TGME49_221450 | SPRY domain-containing protein |
Theileria parva | TP03_0423 | hypothetical protein |
Trichomonas vaginalis | TVAG_127960 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_499590 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_282630 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_Y17G7B.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y17G7B.2 | Caenorhabditis elegans | larval arrest | wormbase |
TGME49_221450 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ash2 (absent, small, or homeotic)-like (Drosophila) | Compounds | References |